Discover
EMBC
Embecta Corp.
3.36
2 x 2.47
1 x 3.40
bid
ask
+
0.10
3.07%
2 @ 04:00 AM
3.35 -0.01 (0.16%)
| Ytd | -71.72% | |
| 1y | -67.25% |
3.28
day range
3.48
2.77
52 week range
15.55
| Open | 3.28 | Prev Close | 3.26 | Low | 3.28 | High | 3.48 | Mkt Cap | 199.34M |
| Vol | 2.02M | Avg Vol | 2.37M | EPS | 1.89 | P/E | 1.78 | Forward P/E | 5.95 |
| Beta | 1.15 | Short Ratio | 4.13 | Inst. Own | 98.19% | Dividend | 0.60 | Div Yield | 4.47 |
| Ex Div Date | 02-28 | Earning | 08-06 | 50-d Avg | 4.45 | 200-d Avg | 9.98 | 1yr Est | 22.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2025-02-06 | 2024-12 | 0.45 | 0.65 | 0.2 | 44.44% |
| 2024-11-26 | 2024-09 | 0.4 | N/A | N/A | N/A |
| 2024-11-26 | 2024-09 | 0.4 | 0.45 | 0.05 | 12.50% |
| 2024-08-09 | 2024-06 | 0.48 | 0.74 | 0.26 | 54.17% |
| 2024-08-09 | 2024-06 | 0.48 | N/A | N/A | N/A |
| 2024-05-09 | 2024-03 | 0.43 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-27 | BTIG | Upgrade | Neutral | Buy |
| 2024-07-15 | Morgan Stanley | Upgrade | Underweight | Underweight |
| 2024-05-10 | Morgan Stanley | Upgrade | Underweight | Underweight |
| 2023-11-22 | Morgan Stanley | Upgrade | Underweight | Underweight |
| 2023-10-18 | Morgan Stanley | Upgrade | Underweight | Underweight |
| 2023-08-24 | Morgan Stanley | Upgrade | Underweight | Underweight |
Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-02-11 | ALBRITTON DAVID | Director | 39.74K | Stock Award(Grant) |
| 2025-02-11 | ANDERSON CARRIE L | Director | 39.74K | Stock Award(Grant) |
| 2024-11-25 | CASNER JEAN | Officer | 48.29K | Stock Award(Grant) |
| 2025-02-11 | HOMBACH ROBERT J. CPA | Director | 39.75K | Stock Award(Grant) |
| 2025-02-24 | MELCHER DAVID F. | Director | 76.68K | Purchase |
| 2025-02-12 | MORRIS MILTON MAYO | Director | 36.13K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-12-30 | Blackrock Inc. | 9.31M | 125.63M | 16.01% |
| 2024-12-30 | Vanguard Group Inc | 7.03M | 94.84M | 12.08% |
| 2024-12-30 | Deerfield Management Company, L.P. (Series C) | 3.27M | 44.15M | 5.63% |
| 2024-12-30 | American Century Companies Inc | 3.26M | 44.04M | 5.61% |
| 2024-12-30 | River Road Asset Management, LLC | 3.25M | 43.84M | 5.59% |
| 2024-12-30 | FMR, LLC | 2.49M | 33.63M | 4.29% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-12-30 | iShares Core S&P Smallcap ETF | 3.76M | 50.74M | 6.47% |
| 2024-12-30 | American Century Small Cap Value Fund | 2.43M | 32.81M | 4.18% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 1.91M | 25.75M | 3.28% |
| 2024-10-30 | Fidelity Low-Priced Stock Fund | 1.68M | 22.63M | 2.88% |
| 2024-09-29 | AMG Yacktman Fd | 1.60M | 21.60M | 2.75% |
| 2024-12-30 | iShares Russell 2000 ETF | 1.55M | 20.99M | 2.67% |
Dividend
| Dividend | Date |
|---|---|
| 0.01 | 2026-05-28 |
| 0.15 | 2026-02-27 |
| 0.15 | 2025-12-05 |
| 0.15 | 2025-08-29 |
| 0.15 | 2025-05-28 |
| 0.15 | 2025-02-28 |